This message contains images. If you don't see images, click here to view.
Advertise in this news brief.



Text version   RSS   Subscribe   Unsubscribe   Archive   Media Kit April 30, 2015
Advertisement
   NAMCP Medical Directors Institute   AAMCN    AAIHDS    Conferences    JMCM    Contact Us  

Check out JMCM’s new website at www.jmcmpub.org

We wanted you to be aware that the FDA has granted accelerated approval of IBRANCE® (palbociclib) for the treatment of postmenopausal women with ER+/HER2- advanced breast cancer. Click here to see the press release!

We wanted you to be aware that FDA-approved Hysingla™ ER (hydrocodone bitartrate) extended-release tablets CII has commercially launched in the U.S. Please click here to view the press release.

Click here for a CME/CEU activity on Improving Treatment of Atrial Fibrillation and Stoke

Otezla® (apremilast) is approved for the treatment of patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy. Please click here for more information.

Click here to view our Complimentary Online CME/CEU Webcasts

 


GENOMICS

How an RNA gene silences a whole chromosome
ScienceDaily
Researchers have discovered how an abundant class of RNA genes, called lncRNAs can regulate key genes. By studying an important lncRNA, called Xist, the scientists identified how this RNA gathers a group of proteins and ultimately prevents women from having an extra functional X-chromosome — a condition in female embryos that leads to death in early development.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE  




New analysis finds that rates of health insurance coverage vary by demographics, cancer type
News-Medical.net
A new analysis has found that, among patients with cancer, rates of health insurance coverage vary by patient demographics and by cancer type. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings suggest that the expansion of coverage through the Affordable Care Act may disproportionally benefit certain patient populations.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


New breast cancer gene identified
Medical Xpress
A new breast cancer gene has been identified in a study led by Women's College Hospital researcher Dr. Mohammad Akbari, who is also an assistant professor with the Dalla Lana School of Public Health at the University of The study published in Nature Genetics describes how mutations in a gene called RECQL are strongly linked to the onset of breast cancer in two populations of Polish and French-Canadian women.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


SPONSORED CONTENT


Chinese manipulation of human embryo genes draws rebuke
The Wall Street Journal
A team of Chinese scientists have reported using human embryos as subjects for an experiment in editing genes in a way that could be passed on permanently — a practice believed to be a first and also hotly opposed by most genetic researchers and ethicists internationally.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


BIOTECH/DIAGNOSTICS/PERSONALIZED MEDICINE


Personalized medicine: Time for one-person trials
Nature
Every day, millions of people are taking medications that will not help them. The top 10 highest-grossing drugs in the United States help between 1 in 25 and 1 in 4 of the people who take them. For some drugs, such as statins — routinely used to lower cholesterol — as few as 1 in 50 may benefit.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PRODUCT SHOWCASE
  Measure, Monitor Immunoglobulin Treatment Outcomes
BioFeedback for immunoglobulin is a health outcomes reporting program that provides clinical feedback on the use of immunoglobulin in autoimmune-related disorders. Physicians and medical directors can now deploy clinical interventions when they have the greatest impact on healthcare quality and costs.

Request more information or schedule a personal introduction.
 


Personalized medicine: Device identifies drugs that will work best for each patient
ScienceDaily
More than 100 drugs have been approved to treat cancer, but predicting which ones will help a particular patient is an inexact science at best. A new device developed at MIT may change that. The implantable device, about the size of the grain of rice, can carry small doses of up to 30 different drugs.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


REGENERATIVE MEDICINE


Stem cell transplantation for multiple myeloma: New data did not change conclusion
ScienceDaily
An update search enlarged the pool of study data, but did not change the content of the conclusion of the benefit assessment of stem cell transplantation for multiple myeloma conducted in 2012. Overall, the evidence base remained insufficient: Until now, data on quality of life have not been recorded in any study at all.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




Stem cells grow on dead feeder cells
Genetic Engineering and Biotechnology News
Scientists have long known that stem cells naturally cling to feeder cells as they grow in petri dishes. Researchers have thought that this attachment occurs because feeder cells serve as a support system, providing stems cells with essential nutrients.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Mitochondria's other job is to control stem cell development
Medical News Today
In a remarkable discovery, scientists show that blocking the action of a key enzyme in mitochondria stops stem cells from developing into egg cells in fruit flies. Mitochondria — tiny digestive systems found inside nearly every cell of the body — are traditionally known for their vital role in generating energy for cells to function.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


  FEATURED COMPANIES
SOAPware. Exceptional Software. Empowering Healthcare.
Ranked #1 in the Nation for Quality of Care. Our Meaningful Use certified software is designed by medical providers, making SOAPware the preferred EHR for medical professionals! MORE
Advertise here!

To find out how to feature your company in the GBEMTI eNewsletter and other advertising opportunities, Contact Geoffrey Forneret at 469-420-2629.
MORE


EMERGING MEDICAL TECHNOLOGIES


Infographic: How healthcare technology is saving lives
HIT Consultant
We live in an age where the use of technology dominates our lives and these technological developments have had an amazingly positive impact on the healthcare industry. Digital health technology has heavily influenced the improvement in our health and the increased life expectancy we are seeing today.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


How Apple Pay is streamlining healthcare payments
CIO
Mobile payments are the future; at least that's what we keep hearing. Maybe you've used Apple Pay yourself or noticed someone in line holding her smartphone up to a credit card reader. It's only been around for about six months, but according to Apple, Apple Pay is already accepted at hundreds of thousands of retail stores.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


ACCOUNTABLE CARE ORGANIZATIONS


No ACOs without coordination
Healthcare IT News
For providers considering how to assemble a viable accountable care organization, experts say the key is to first have a strong care coordination system in place. Without cohesion and collaboration among clinicians, an ACO has no chance of getting off the ground, says John Shankman, senior vice president of clinical innovation for New York-based AMC Health.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


ACO expansion: A costly but vital sustainability investment
RevCycle Intelligence
The number of accountable care organizations is on the rise, albeit a tad slowly, confirms new research from Niyum Ghandi, Partner at Oliver Wyman. There has been active ACO expansion activity with the healthcare indsutry. Ghandi’s findings specifically verify the establishment of an additional 159 ACOs, bringing the estimated total up to 585.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


FDA: NEW TREATMENTS AND TECHNOLOGY


FDA may crack down on junk homeopathic 'remedies'
The Verge
The FDA is asking for input on how to deal with homeopathic "remedies," concoctions with no proof they work that haven't faced the scrutiny of regular medicine. Homeopathy operates under the idea that heavily diluted substances in the body can trigger a response that fights disease, but most scientists have called the idea bunk.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


FDA considers new treatment for double chins
WFOR-TV
The U.S. Food and Drug Administration is considering a new treatment meant to reduce the double chin using a drug, not surgery. “If it’s a simple injection and it’s painless, and it’s going to help me feel better about myself, yeah, I’d do it,” said one man.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


MANAGED HEALTHCARE NEWS


What employers need to know about the hottest trend in health insurance
Entrepreneur
There are a number of industry trends employers should be aware of in preparation for open enrollment. Of those trends, there’s one that continues to rise in popularity: consumer-driven healthcare plans. In fact, last year, offerings of consumer-driven healthcare plans jumped from 39 percent to 48 percent among employers with 500 or more employees, according to Mercer’s National Survey of Employer-Sponsored Health Plans.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Survey: Out-of-pocket costs for healthcare up 11 percent
FoxBusiness
Both healthcare consumers and providers felt the squeeze of rising healthcare costs in 2014 — with out-of-pocket costs for patients rising 11 percent — according to a TransUnion Healthcare report released. “Our latest report demonstrates that consumers continue to feel the pressure of rising healthcare costs,” said Gerry McCarthy, president of TransUnion Healthcare.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


TRENDING ARTICLES
Missed last week's issue? See which articles your colleagues read most.

    10 super-genes that scientists could someday program into your body (Business Insider)
IBM's Watson promises breakthroughs in personalized medicine (Genetic Literary Project)
Is the placebo effect in some people's genes? (Reuters)
Cancer gene unintentionally ends the life of cancer cells, turns off life supporting genes (Medical Xpress)
Merck's Keytruda shrinks lung cancer tumors, FDA approval sought (Reuters via Fox News)

Don't be left behind. Click here to see what else you missed.
 

Genomics Biotech and Emerging Medical Technologies Institute eBrief
Colby Horton, Vice President of Publishing, 469.420.2635
Download media kit

Natalie Rodriguez, Senior Content Editor, 469.420.2635   
Contribute news

This edition of the Genomics Biotech and Emerging Medical Technologies Institute eBrief was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!
Recent issues
April 23, 2015
April 16, 2015
April 9, 2015
April 2, 2015



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063